U.S. Pharmacist Weekly News Update
October 24, 2018

Pharmacists Can’t Offer Much Proven Relief for the
Common Cold

Not much clinical evidence exists for effectively treating cold symptoms, according to a new study, which puts pharmacists in a bind when asked for advice. A new review offers some possible measures for adults, but strongly cautions against use of decongestants in younger children. Here are the details.


Hundreds of Supplements Have Undeclared, Potentially
Harmful Ingredients

Do you know what’s on your drugstore shelves? A study of dietary supplements included in FDA warnings notes that more than 700 OTC products were found to contain pharmaceuticals that were undeclared or possibly harmful. Which supplements are most likely to include those ingredients?

AEDs Linked to Increased Stroke Risk in Alzheimer's 
Disease Patients

Patients with Alzheimer's disease are more frequent users of antiepileptic drugs (AEDs), partly because they are more predisposed to seizures. A new study has found a disturbing association, however, between use of AEDs in that cohort and risk of stroke. Pharmacists might want to know if the risk was the same for both newer and older AEDs.

Jury Is Still Out on Benefit of Statins for Noncardiovascular Conditions
With so many studies finding noncardiovascular benefits for statins, pharmacists may wonder why clinical guidelines haven’t changed to reflect that. A review of research suggests that the evidence isn’t quite there yet. Here is more information.

Connect With U.S. Pharmacist
Facebook Twitter USP Google AppUSP Itunes App